Sulfoxime

Sulfoxime (à ne pas confondre avec Sulfoximine) est une substance, avec des soi-disant effets antimicrobiens, inventée par le pseudo-scientifique américain des US Robert Bradford qui est commercialisée, entre autres produits, par sa firme "American Biologics" à Chula Vista (Californie). Selon la demande d'enregistrement de la marque, il s'agirait d'un composé de soufre organique ^[1]. On ne trouve aucune description exacte de ladite substance.

Selon la publicité pour la Sulfoxime, la substance serait utile pour le traitement de la Borréliose ou de la fibromyalgie. A ce propos, Bradford affirme que la fibromyalgie serait une maladie infectieuse qui serait provoquée par des bactéries ou des champignons, sans autres précisions. Au sujet de la Sulfoxime Bradford déclare que la substance pourrait détruire sélectivement les "membranes" des champignons.

Cependant, il n'y a pas de preuves scientifiques étayant cette affirmation. L'autorité de réglementation canadienne Health Canada met en garde contre l'utilisation de Sulfoxime et d'autres produits de "American Biologics". ^[2]

L'insecticide chinois Sulfoxime

En Chine, il y a un insecticide connu sous le nom de "Sulfoxime" (IUPAC: (RS)-[1-(4-chlorophenyl)-2-(methylthio)-1-propanone] (EZ)-O-(3-phenoxybenzyl)oxime) (CAS: 1-(4-chlorophenyl)-2-(methylthio)-1-propanone O-[(3-phenoxyphenyl)methyl]oxime), son nom ne semble cependant pas être utilisé en dehors de la Chine.

Références

↑ https://inventively.com/search/trademarks/76320796
↑ http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2006/13148a-eng.php October 13, 2006
Health Canada is warning consumers and health practitioners not to use the unauthorized intravenous products Bismacine (also known as Chromacine), Dioxychlor (also known as DC-3) and Sulfoxime because they may pose a serious risk to health.

These products have been promoted as an intravenous protocol to treat Lyme disease, a tick-bourne illness. Additionally, Dioxychlor and Sulfoxime injections have been promoted for the treatment of other health conditions. Together, Sulfoxime and Dioxychlor are promoted as anti-microbial agents.

Bismacine is not an authorized health product in Canada; however, it has been available for sale from compounding pharmacies in the United States. Bismacine contains high amounts of bismuth, a heavy metal that is authorized for use in some oral medications to treat Helicobacter pylori, a bacterium that can cause stomach ulcers. However, using bismuth through injection may result in cardiovascular collapse, kidney failure or death.

There is evidence that Dioxychlor and Sulfoxime, although not authorized by Health Canada, have been purchased by Canadians, in Ontario, Quebec and Nova Scotia, from a U.S. Internet pharmacy.

Bismacine, Dioxychlor or Sulfoxime injections are not recognized naturopathic practices in Canada and they are not used by licensed naturopathic doctors in Canada for the treatment of Lyme disease or any other condition.

All three products are manufactured by American Biologics of Chula Vista, California. The same manufacturer markets a device called the Bradford High Resolution Microscope as a tool to diagnose Lyme disease. This device has not been reviewed or approved by Health Canada.

Lyme disease occurs mainly during the summer. It is treated with antibiotics, either orally or intravenously, depending on the severity of the disease. Visit the It's Your Health fact sheet for more information on Lyme disease.

To date, no adverse reactions suspected to be associated with these products have been reported to Health Canada. However, there has been one death and several reports of injury related to treatment with Bismacine in the United States.

Health Canada is advising consumers and health practitioners not to use Bismacine, Dioxychlor or Sulfoxime for the treatment of any medical condition, including Lyme disease. Individuals who believe they have suffered side-effects from using these products are advised to seek medical attention immediately. Health Canada is also advising consumers and health practitioners not to use the Bradford High Resolution Microscope to diagnose any medical condition.

[1] ttps://inventively.com/search/trademarks/76320796

[2] ttp://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2006/13148a-eng.php October 13, 2006
Health Canada is warning consumers and health practitioners not to use the unauthorized intravenous products Bismacine (also known as Chromacine), Dioxychlor (also known as DC-3) and Sulfoxime because they may pose a serious risk to health.

These products have been promoted as an intravenous protocol to treat Lyme disease, a tick-bourne illness. Additionally, Dioxychlor and Sulfoxime injections have been promoted for the treatment of other health conditions. Together, Sulfoxime and Dioxychlor are promoted as anti-microbial agents.

Bismacine is not an authorized health product in Canada; however, it has been available for sale from compounding pharmacies in the United States. Bismacine contains high amounts of bismuth, a heavy metal that is authorized for use in some oral medications to treat Helicobacter pylori, a bacterium that can cause stomach ulcers. However, using bismuth through injection may result in cardiovascular collapse, kidney failure or death.

There is evidence that Dioxychlor and Sulfoxime, although not authorized by Health Canada, have been purchased by Canadians, in Ontario, Quebec and Nova Scotia, from a U.S. Internet pharmacy.

Bismacine, Dioxychlor or Sulfoxime injections are not recognized naturopathic practices in Canada and they are not used by licensed naturopathic doctors in Canada for the treatment of Lyme disease or any other condition.

All three products are manufactured by American Biologics of Chula Vista, California. The same manufacturer markets a device called the Bradford High Resolution Microscope as a tool to diagnose Lyme disease. This device has not been reviewed or approved by Health Canada.

Lyme disease occurs mainly during the summer. It is treated with antibiotics, either orally or intravenously, depending on the severity of the disease. Visit the It's Your Health fact sheet for more information on Lyme disease.

To date, no adverse reactions suspected to be associated with these products have been reported to Health Canada. However, there has been one death and several reports of injury related to treatment with Bismacine in the United States.

Health Canada is advising consumers and health practitioners not to use Bismacine, Dioxychlor or Sulfoxime for the treatment of any medical condition, including Lyme disease. Individuals who believe they have suffered side-effects from using these products are advised to seek medical attention immediately. Health Canada is also advising consumers and health practitioners not to use the Bradford High Resolution Microscope to diagnose any medical condition.

[1]

[2]